NASDAQ:LHCG - LHC Group Stock Price, Forecast & News

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) released its quarterly earnings data on Wednesday, February, 26th. The health services provider reported $1.15 earnings per share for the quarter, hitting the consensus estimate of $1.15. The health services provider earned $531.32 million during the quarter, compared to analysts' expectations of $541.57 million. LHC Group had a return on equity of 9.52% and a net margin of 4.60%. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, May 13th 2020. View Earnings Estimates for LHC Group.

LHC Group issued an update on its FY20 earnings guidance on Wednesday, February, 26th. The company provided earnings per share (EPS) guidance of $4.60-4.80 for the period, compared to the Thomson Reuters consensus estimate of $4.74. The company issued revenue guidance of $2.13-2.18 billion, compared to the consensus revenue estimate of $2.24 billion.

11 brokers have issued twelve-month target prices for LHC Group's stock. Their forecasts range from $114.00 to $160.00. On average, they expect LHC Group's share price to reach $136.80 in the next year. This suggests a possible upside of 12.6% from the stock's current price. View Analyst Price Targets for LHC Group.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

Media headlines about LHCG stock have been trending very negative recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. LHC Group earned a coverage optimism score of -4.0 on InfoTrie's scale. They also gave news articles about the health services provider a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near future. View News Stories for LHC Group.

LHC Group saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,850,000 shares, an increase of 9.5% from the January 15th total of 1,690,000 shares. Based on an average trading volume of 200,700 shares, the short-interest ratio is currently 9.2 days. Currently, 6.2% of the company's stock are sold short. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), BioScrip (BIOS), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), Home Depot (HD), Cisco Systems (CSCO), Alibaba Group (BABA), CVS Health (CVS), Visa (V), Chevron (CVX), NVIDIA (NVDA), Walt Disney (DIS) and AT&T (T).

LHC Group's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (5.29%), State Street Corp (2.77%), Alliancebernstein L.P. (2.13%), Victory Capital Management Inc. (2.12%), Victory Capital Management Inc. (2.10%) and Bank of New York Mellon Corp (1.91%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Redwood Investments LLC, Rothschild & Co. Asset Management US Inc., Man Group plc, Robeco Institutional Asset Management B.V., Principal Financial Group Inc., Sei Investments Co., Arizona State Retirement System and Loomis Sayles & Co. L P. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, John L Indest, Joshua L Proffitt, Keith G Myers and Ronald T Nixon. View Insider Buying and Selling for LHC Group.

LHCG stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Magnetar Financial LLC, Sumitomo Mitsui Trust Holdings Inc., Janus Henderson Group PLC, Westwood Management Corp IL, Columbus Circle Investors, Bank of New York Mellon Corp and Victory Capital Management Inc.. View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $121.46.

LHC Group has a market capitalization of $3.83 billion and generates $2.08 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $4.47 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]